Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed Mar 28, 2023 · 10-K · 87 days after period end · 0001091818-23-000044
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $1.00 |
| Net Income | -$114.74K | -$120.70K | -$122.57K | -$20.17K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 28, 2023 · 87 d after period end
